Qt Imaging Holdings (QTI) Income from Continuing Operations (2021 - 2026)
Qt Imaging Holdings (QTI) posted quarterly Income from Continuing Operations of 5656000.0 for Q1 2026, up 42.23% year-over-year from 3976583.08 in Q1 2025, and down 307.47% quarter-over-quarter from 1388079.0 in Q4 2025.
Qt Imaging Holdings (QTI) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has reported Income from Continuing Operations for 6 consecutive years, with 5656000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 42.23% year-over-year to 5656000.0; the TTM figure through Mar 2026 stood at 15603000.0 (up 14.02% YoY), while the FY2025 annual figure was 21083000.0, down 134.65% from the prior year.
- Income from Continuing Operations retreated to 5656000.0 in Q1 2026 per QTI's latest filing, from 1388079.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 369935.0 in Q1 2022 and bottomed at 9791000.0 in Q1 2025.
- Historically, Income from Continuing Operations has averaged 2760132.82 across 5 years, with a median of 1500691.0 in 2023.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 934.81% — and 2025, when it soared 60.2%.
- Qt Imaging Holdings' Income from Continuing Operations stood at 1372532.0 in 2022, then climbed by 14.34% to 1175705.0 in 2023, then slumped by 196.68% to 3488042.0 in 2024, then jumped by 60.2% to 1388079.0 in 2025, then slumped by 307.47% to 5656000.0 in 2026.
- Business Quant data shows QTI's Income from Continuing Operations at 5656000.0 in Q1 2026, 1388079.0 in Q4 2025, and 4557406.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Qt Imaging Holdings | 41.16 Mn | 30.23 Mn | 3.06 Mn | -11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.07 Mn |
| Mar 31, 2026 | -5.66 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -4.56 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -9.79 Mn |
| Dec 31, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -4.30 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -1.43 Mn |
| Mar 31, 2023 | -1.99 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -395,766.00 |
| Jun 30, 2022 | -636,074.00 |
| Mar 31, 2022 | -369,935.00 |
| Dec 31, 2021 | -867,753.00 |
| Sep 30, 2021 | -204,228.00 |